Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Receptor (PPAR gamma).php on line 2
Receptor (PPAR gamma)
LE WE PMID CA
Receptor (PPAR gamma)2266Rezeptoren (PPAR gamma)

1 1 Bis 3 indolyl 1 p substituted phenyl methanes C DIM

ABCA1

ABCC8 SUR1

ABCG1

AEBP1

Aleglitazar

Anemia (megaloblastic thiamine responsive)

Atherosclerosis (peripheral vessels)

Bererdinelli Seip congenital lipodystrophy

Bezafibrate

BSCL1 AGPAT2

BSCL2 Seipin

Ciprofibrate

Clofibrate

Colon and rectum (Neoplasia)

Curcumin

Diabetes mellitus (Beta cell decay)

Diabetes mellitus (Hereditary MODY)

Diabetes mellitus (hereditary)

Diabetes mellitus (neonatal)

Donohue s syndrome Leprechaunism

EIF2AK3 PERK

ERS UFR (Diseases)

ERS UFR (Pharmacology)

Fenofibrate

Fibrate

FRDA1 Frataxin

Friedreich ataxia

Gemfibrozil

Glucokinase

GLUD1

Hexarelin

Huntington s disease

Imiglitazar

Insulin resistance type a

JNK

KCNJ11 Kir6 2

Lipodystrophy

Macelignan

Macrophages

Mitochondria (Dysfunction)

Muraglitazar

NR1C1 PPAR alpha

NR1H3 LXRalpha

NR4A1 Nur77

OMIM_601487

OMIM_x600937

Persistent hyperinsulinemic hypoglycemia of infancy

Persistent neonatal hypoglycemia

RAAS (Angiotensin receptor blockers)

Rabson Mendenhall s syndrome

Ragaglitazar

Receptor (Insulin)

Receptor (oxLDL)

Receptor (PPAR beta)

Receptor (PPAR delta)

Receptor (PPAR gamma)

Receptor (RXR)

SLC19A2 THTR1

Telmisartan

Tesaglitazar

TNDM29locus

Werner s syndrome

Wfs1 Wolframin

Wfs2

Wolcott Rallison syndrome

Wolfram s syndrome DIDMOAD

WRN

2008  
1
Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer types.
[18779871] PPAR Res 2008(-): 494161 (2008)
2008  
2
Activated PPARgamma Targets Surface and Intracellular Signals That Inhibit the Proliferation of Lung Carcinoma Cells.
[18704200] PPAR Res 2008(-): 254108 (2008)
2008  
3
A Novel Mechanism of PPARgamma Regulation of TGFbeta1: Implication in Cancer Biology.
[18615188] PPAR Res 2008(-): 762398 (2008)
2008  
4
PPARgamma and MEK Interactions in Cancer.
[18596912] PPAR Res 2008(-): 309469 (2008)
2008  
5
PPARgamma and PPARdelta as Modulators of Neoplasia and Cell Fate.
[18566686] PPAR Res 2008(-): 247379 (2008)
2008  
6
Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.
[18528526] PPAR Res 2008(-): 181047 (2008)
2008  
7
Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignancies.
[18528522] PPAR Res 2008(-): 834612 (2008)
2008  
8
Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer.
[18464916] PPAR Res 2008(-): 431763 (2008)
2008  
9
Hexarelin Signaling to PPARgamma in Metabolic Diseases.
[18288286] PPAR Res 2008(-): 364784 (2008)
2007  
10
Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-gamma Activation.
[18274631] PPAR Res 2007(-): 89369 (2007)
2007  
11
Fat poetry: a kingdom for PPAR gamma.
[17563755] Cell Res 17(6): 486-511 (2007)
2003  
12
Peroxisome proliferator-activated receptor gamma and cancers.
[12538445] Clin Cancer Res 9(1): 1-9 (2003)
2006  
13
Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism.
[17018837] Endocr Rev 27(7): 728-35 (2006)
2003  
14
Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator.
[12588810] Endocr Rev 24(1): 78-90 (2003)
1999  
15
Peroxisome proliferator-activated receptors: nuclear control of metabolism.
[10529898] Endocr Rev 20(5): 649-88 (1999)
2005  
16
PPARgamma-mediated insulin sensitization: the importance of fat versus muscle.
[15637349] Am J Physiol Endocrinol Metab 288(2): E287-91 (2005)
2002  
17
Peroxisome proliferator-activated receptor gamma agonists: potential use for treating chronic inflammatory diseases.
[11920394] Arthritis Rheum 46(3): 598-605 (2002)
2006  
18
Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.
[16728570] Endocr Relat Cancer 13(2): 401-13 (2006)
2003  
19
The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulation.
[12788836] J Clin Endocrinol Metab 88(6): 2412-21 (2003)
2001  
20
Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis.
[11463572] J Mol Endocrinol 27(1): 1-9 (2001)
2010  
21
From bench to bedside: novel mechanisms and therapeutic advances through the development of selective peroxisome proliferator-activated receptor gamma modulators.
[19923371] Am J Clin Nutr 91(1): 251S-253S (2010)
2010  
22
Selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulation as a strategy for safer therapeutic PPARgamma activation.
[19906796] Am J Clin Nutr 91(1): 267S-272S (2010)
2007  
23
PPARgamma in human and mouse physiology.
[17475546] Biochim Biophys Acta 1771(8): 999-1013 (2007)
2007  
24
MAPK kinases as nucleo-cytoplasmic shuttles for PPARgamma.
[17611413] Cell Cycle 6(13): 1539-48 (2007)
2011  
25
Role of peroxisome proliferator-activated receptor-γ in atherosclerosis: an update.
[21325726] Circ J 75(3): 528-35 (2011)
2008  
26
Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
[18276926] Circ Res 102(3): 283-94 (2008)
2008  
27
Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men.
[18323516] Arterioscler Thromb Vasc Biol 28(6): 1050-9 (2008)
2010  
28
The nuclear hormone receptor PPARγ as a therapeutic target in major diseases.
[21057731] ScientificWorldJournal 10(-): 2181-97 (2010)
2002  
29
PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism.
[11861659] J Lipid Res 43(2): 177-86 (2002)
2010  
30
New standards in hypertension and cardiovascular risk management: focus on telmisartan.
[20448797] Vasc Health Risk Manag 6(-): 113-33 (2010)
2008  
31
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.
[17981670] Front Biosci 13(-): 1813-26 (2008)
2008  
32
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase.
[18460448] Carcinogenesis 29(6): 1139-47 (2008)
2007  
33
1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth.
[18006776] Clin Cancer Res 13(22 Pt 1): 6743-52 (2007)
2008  
34
Therapeutic potential of peroxisome proliferators--activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes.
[18065517] Diabetes 57(3): 737-45 (2008)
2010  
35
Peroxisome proliferator-activated receptor γ and colorectal cancer.
[21160824] World J Gastrointest Oncol 2(3): 159-64 (2010)
2011  
36
Medicinal Chemistry and Actions of Dual and Pan PPAR Modulators.
[21966330] Open Med Chem J 5(Suppl 2): 93-8 (2011)
2011  
37
PPARγ agonist beyond glucose lowering effect.
[21437157] Korean J Intern Med 26(1): 19-24 (2011)
2005  
38
Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and beta cell failure.
[15772126] J Med Genet 42(12): 893-902 (2005)
2010  
39
Anticancer actions of PPARγ ligands: Current state and future perspectives in human lung cancer.
[21537367] World J Biol Chem 1(3): 31-40 (2010)
2009  
40
PPARgamma and its ligands: therapeutic implications in cardiovascular disease.
[19118492] Clin Sci (Lond) 116(3): 205-18 (2009)
2010  
41
The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.
[20556492] J Bioenerg Biomembr 42(3): 199-205 (2010)
2010  
42
PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1.
[20419060] Nucl Recept Signal 8(-): e004 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Receptor (PPAR gamma).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Receptor (PPAR gamma).php on line 92